[HTML][HTML] Long-term effects of caffeine therapy for apnea of prematurity
B Schmidt, RS Roberts, P Davis… - … England Journal of …, 2007 - Mass Medical Soc
Background Methylxanthine therapy is commonly used for apnea of prematurity but in the
absence of adequate data on its efficacy and safety. It is uncertain whether methylxanthines …
absence of adequate data on its efficacy and safety. It is uncertain whether methylxanthines …
Long-term effects of caffeine therapy for apnea of prematurity.
B Schmidt, RS Roberts, P Davis, LW Doyle… - The New England …, 2007 - europepmc.org
Background Methylxanthine therapy is commonly used for apnea of prematurity but in the
absence of adequate data on its efficacy and safety. It is uncertain whether methylxanthines …
absence of adequate data on its efficacy and safety. It is uncertain whether methylxanthines …
[PDF][PDF] Long-Term Effects of Caffeine Therapy for Apnea of Prematurity
B Schmidt, RS Roberts, P Davis, LW Doyle… - N Engl J …, 2007 - stat.wmich.edu
ABSTRACT From the Department of Clinical Epidemiology and Biostatistics, McMaster
University, Hamilton, ON, Canada (BS, RSR, AO); the Department of Obstetrics and …
University, Hamilton, ON, Canada (BS, RSR, AO); the Department of Obstetrics and …
Long-Term Effects of Caffeine Therapy for Apnea of Prematurity
B Schmidt, RS Roberts, P Davis - N Engl J Med, 2007 - journals.lww.com
Infants enrolled in the study were given caffeine to prevent or treat apnea and to facilitate
removal of an endotracheal tube. In a randomized manner, infants received either normal …
removal of an endotracheal tube. In a randomized manner, infants received either normal …
Long-term effects of caffeine therapy for apnea of prematurity
B Schmidt, RS Roberts, P Davis, LW Doyle… - New England Journal …, 2007 - hero.epa.gov
BACKGROUND: Methylxanthine therapy is commonly used for apnea of prematurity but in
the absence of adequate data on its efficacy and safety. It is uncertain whether …
the absence of adequate data on its efficacy and safety. It is uncertain whether …
Long-term effects of caffeine therapy for apnea of prematurity
B Schmidt, RS Roberts, P Davis, LW Doyle… - 2007 - pubmed.ncbi.nlm.nih.gov
Background Methylxanthine therapy is commonly used for apnea of prematurity but in the
absence of adequate data on its efficacy and safety. It is uncertain whether methylxanthines …
absence of adequate data on its efficacy and safety. It is uncertain whether methylxanthines …
[PDF][PDF] Long-term effects of caffeine therapy for apnea of prematurity
B Schmidt - 2008 - academia.edu
Authors: Schmidt B et al Summary: This study examined the long-term effects of
methylxanthine therapy on neurodevelopment and growth in infants treated for apnea of …
methylxanthine therapy on neurodevelopment and growth in infants treated for apnea of …
[引用][C] Long-term effects of caffeine therapy for apnea of prematurity
B SCHMIDT - N Engl J Med, 2007 - cir.nii.ac.jp
[引用][C] Long-term effects of caffeine therapy for apnea of prematurity
B SCHMIDT, RS ROBERTS, P DAVIS… - The New England …, 2007 - pascal-francis.inist.fr
Long-term effects of caffeine therapy for apnea of prematurity CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
Long-Term Effects of Caffeine Therapy for Apnea of Prematurity
B Schmidt, RS Roberts, P Davis - N Engl J Med, 2007 - journals.lww.com
Infants enrolled in the study were given caffeine to prevent or treat apnea and to facilitate
removal of an endotracheal tube. In a randomized manner, infants received either normal …
removal of an endotracheal tube. In a randomized manner, infants received either normal …